Effectiveness of a Manual Therapy Protocol in Patients With Masticatory Muscle Disorders
Launched by UNIVERSITY OF ALCALA · Jun 2, 2018
Trial Information
Current as of August 14, 2025
Completed
Keywords
ClinConnect Summary
The investigators want to get better insights into the outcome of a manual therapy protocol compare with effleurage. The treatment is meant for people who has masticatory muscle disorders. Besides, if the trial can reduce the pain's intensity and the trial can improve range of motion in the dysfunction of temporomandibular joint. The results will be register on the short and long term.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are between 18 and 60 years old.
- • Patients who have myofascial pain or myofascial pain and restricted oral opening taking into account Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).
- • Patients who have pain in their masticatory muscles while they are doing functional activities with their temporomandibular joint for, at least, the last six months.
- Exclusion Criteria:
- • Patients who cannot receive manual therapy.
- • Patients who took or have been taking pills in the last two months before they start in the trial like: antidepressants, antiepileptics, muscle relaxants or medications for metabolic diseases; because they affect the musculoskeletal system.
- • Surgery intervention in the temporomandibular joint.
- • Patients who have received physiotherapy sessions in the last six months.
- • Red flags: malignant or inflammatory tumors, infectious diseases that contraindicate manual therapy, cervical surgery, previous history of whiplash, fibromyalgia, trigeminal neuralgia, osteoarthritis or rheumatoid arthritis.
- • Patients who lost their teeth (excluding the third molar) or people using a total or partial dentures.
About University Of Alcala
The University of Alcalá, a prestigious institution located in Spain, is committed to advancing medical research and innovation through its clinical trial sponsorship. With a strong emphasis on interdisciplinary collaboration and ethical standards, the university leverages its academic expertise and state-of-the-art facilities to facilitate groundbreaking studies in various fields of healthcare. By fostering partnerships with industry leaders and healthcare professionals, the University of Alcalá aims to enhance patient outcomes and contribute to the global body of medical knowledge. Its dedication to rigorous research methodologies ensures the integrity and reliability of clinical trials, promoting a culture of excellence in scientific inquiry.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alcalá De Henares, Madrid, Spain
Patients applied
Trial Officials
Beatriz M. Bravo, Physiotherapy
Principal Investigator
Investigator
Inmaculada T. Tejada, Physiotherapy
Principal Investigator
Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials